A recent retrospective study (AF Kane et al. J Pediatr 2018; 195: 73-9) with 640 VLBW infants found that the probiobiotic, Lactobacillus rhamnosus GG (LGG), was associated with an increased risk of necrotizing enterocolitis (NEC).
LGG supplementation was started at a median age of 6 days at a dose of 2.5 to 5 x 10 to the 9th CFU/day.
- LGG group had an aOR of 2.10 for developing NEC. LGG group NEC incidence was 16.8% whereas NEC incidence was 10.2% prior to institution of LGG.
The authors note their findings are in contrast to findings from 38 randomized trials (10,520) which have found that probiotics lowered the risk of NEC.
My take: This study reinforces the need for further studies to identify which factors and probiotic strains are likely to lead to reduced rates of NEC.
Related blog posts:
- Probiotics -Another Positive Study in Prevention of NEC
- Probiotics For NEC -More Work is Needed (part 1 …
- Probiotics for NEC -More Work is Needed (part 2 …
- Therapeutic Inertia in US Neonatal Units (vis-a-vis Probiotics)
- Potential and pitfalls of probiotics with necrotizing enterocolitis